Invention Grant
- Patent Title: Uses of an immunomodulatory protein (GMI) from Ganoderma microsporum
-
Application No.: US12826230Application Date: 2010-06-29
-
Publication No.: US08476238B2Publication Date: 2013-07-02
- Inventor: Jiunn-Liang Ko
- Applicant: Jiunn-Liang Ko
- Applicant Address: TW Taipei County
- Assignee: Mycomagic Biotechnology Co., Ltd.
- Current Assignee: Mycomagic Biotechnology Co., Ltd.
- Current Assignee Address: TW Taipei County
- Agency: WPAT, P.C.
- Agent Anthony King
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K33/24 ; A61P35/04
Abstract:
The invention provides a method for inhibiting EGF receptor activity comprising contacting an EGF receptor with an immunomodulatory protein (GMI) from Ganoderma microsporum, or a recombinant thereof. Also provided is a method for treating invasion and metastasis of cancer cells, comprising administering an effective amount of an immunomodulatory protein (GMI) from Ganoderma microsporum, or a recombinant thereof, to a subject in need of such treatment.
Public/Granted literature
- US20110318429A1 Uses of an Immunomodulatory Protein (GMI) from Ganoderma Microsporum Public/Granted day:2011-12-29
Information query
IPC分类:
